Quick Answer
FATE THERAPEUTICS INC reported Operating Income Loss of -$147.70 million for the year ending 2025.
- FATE THERAPEUTICS INC showed an increase of +29.8% in Operating Income Loss from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), FATE THERAPEUTICS INC's Operating Income Loss has declined by 1,011.1%.
- Historical annual values: Fiscal year 2025: -$147.70 million | Fiscal year 2024: -$210.28 million | Fiscal year 2023: -$190.51 million | Fiscal year 2022: -$308.39 million | Fiscal year 2021: -$216.99 million | Fiscal year 2020: -$128.09 million | Fiscal year 2019: -$100.73 million | Fiscal year 2018: -$67.09 million | Fiscal year 2017: -$42.13 million | Fiscal year 2016: -$31.96 million | Fiscal year 2015: -$27.78 million | Fiscal year 2014: -$24.90 million | Fiscal year 2013: -$17.68 million | Fiscal year 2012: -$13.56 million | Fiscal year 2011: -$13.29 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: